Actively Recruiting

Phase 4
Age: 18Years - 80Years
All Genders
ID07187492

Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia A Prospective, Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Led by Xijing Hospital of Digestive Diseases · Updated on 2026-01-05

180

Participants Needed

1

Research Sites

30 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of Bacillus coagulans on anxiety and depression symptoms in patients diagnosed with functional dyspepsia according to the Rome IV criteria. This clinical trial is designed as a prospective, double-blind, randomized, placebo-controlled study aiming to measure how this probiotic may improve mental health in these patients. The trial is sponsored by Xijing Hospital of Digestive Diseases and plans to enroll 180 participants. Participants will be randomly assigned to one of two groups. Those in the probiotic group with postprandial distress syndrome (PDS) will receive Mosapride Citrate Tablets 5 mg three times daily plus Bacillus coagulans 1050 mg three times daily. Those with epigastric pain syndrome (EPS) will receive Esomeprazole Enteric-Coated Tablets 20 mg once daily plus Bacillus coagulans 1050 mg three times daily. The placebo group will receive the same conventional treatments for PDS or EPS but with a placebo matching Bacillus coagulans in appearance and dose. The treatment duration for all participants is 4 weeks. During the trial, participants' anxiety and depression levels will be assessed using the Hospital Anxiety and Depression Scale (HADS) after the 4-week treatment. Secondary measures include the Overall Treatment Evaluation questionnaire, Global Overall Symptom scale, Short-form Nepean Dyspepsia Index, and Pittsburgh Sleep Quality Index, all evaluated after 4 weeks. After completing the trial, patients will be re-evaluated and their treatment plans adjusted accordingly to monitor treatment effects and safety.

CONDITIONS

Brief Title

Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with functional dyspepsia according to the Rome IV criteria
  • Aged between 18 and 80 years, any gender
  • Hospital Anxiety and Depression Scale (HADS) score between 8 and 14
Not Eligible

You will not qualify if you...

  • Use of probiotics or antibiotics within one month prior to the trial
  • Use of psychoactive medications including hypnotics, sedatives, anxiolytics, or antidepressants within one month prior to the trial
  • Use of hormones, immunosuppressants, or cytotoxic agents within one month prior to the trial
  • Participation in any other clinical trial within one month prior to the study
  • Positive test for Helicobacter pylori infection
  • Long-term use of traditional Chinese herbal medicine
  • Pregnancy or lactation
  • History of drug abuse
  • Comorbidities such as irritable bowel syndrome, gastroesophageal reflux disease, functional constipation, or other significant conditions including severe hepatic, renal, respiratory, or autoimmune disorders; bleeding diatheses; psychiatric diseases; endocrine disorders
  • History of major surgery or diagnosis of diabetes mellitus
  • Refusal to provide written informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 4 weeks

Participants receive assigned medications including Bacillus coagulans or placebo along with standard therapy based on their syndrome type.

Weekly visits for 4 weeks

Trial Site Locations

Total: 1 location

1

Air Force Medical University

Xi’an, Shanxi, China

Actively Recruiting

Loading map...

Research Team

Y

Yongquan Shi Shi

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Erectile Function After Percutaneous Coronary Intervention i...

Erectile Disfunction

Actively Recruiting

1 location

The Effects of Citalopram on the Brain's Response to Emotion...

Emotional Processing

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here